TY - JOUR
T1 - Inducible gene silencing in podocytes
T2 - A new tool for studying glomerular function
AU - Bugeon, Laurence
AU - Danou, Aliki
AU - Carpentier, David
AU - Langridge, Paul
AU - Syed, Nelofer
AU - Dallman, Margaret J.
PY - 2003/3/1
Y1 - 2003/3/1
N2 - Glomerular filtration is one of the primary functions of the kidney. Podocytes, a highly specialized cell type found in glomeruli, are believed to play a critical role in that function. Null mutations of genes expressed in podocytes like WT1, nephrin, and NEPH1 result in an embryo and perinatal lethal phenotype and therefore do not allow the functional analysis of these genes in the adult kidney. Here is describes the generation of a model that will allow such studies. We have engineered transgenic mice in which the disruption of targeted genes can be induced in a temporally controlled fashion in podocytes. For this, a transgene encoding the mutated estrogen receptor-Cre recombinase fusion protein was introduced into the mouse genome. Animals were crossed with Z/AP reporter mice to test for efficient and inducible recombination. We found that, after injection of inducer drug tamoxifen, Cre fusion protein translocates to the nuclei of podocytes, where it becomes active and mediates recombination of DNA carrying loxP target sequences. These animals provide for the first time a tool for silencing genes selectively in podocytes of adult animals.
AB - Glomerular filtration is one of the primary functions of the kidney. Podocytes, a highly specialized cell type found in glomeruli, are believed to play a critical role in that function. Null mutations of genes expressed in podocytes like WT1, nephrin, and NEPH1 result in an embryo and perinatal lethal phenotype and therefore do not allow the functional analysis of these genes in the adult kidney. Here is describes the generation of a model that will allow such studies. We have engineered transgenic mice in which the disruption of targeted genes can be induced in a temporally controlled fashion in podocytes. For this, a transgene encoding the mutated estrogen receptor-Cre recombinase fusion protein was introduced into the mouse genome. Animals were crossed with Z/AP reporter mice to test for efficient and inducible recombination. We found that, after injection of inducer drug tamoxifen, Cre fusion protein translocates to the nuclei of podocytes, where it becomes active and mediates recombination of DNA carrying loxP target sequences. These animals provide for the first time a tool for silencing genes selectively in podocytes of adult animals.
UR - http://www.scopus.com/inward/record.url?scp=0037369893&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037369893&partnerID=8YFLogxK
U2 - 10.1097/01.ASN.0000050222.86847.EA
DO - 10.1097/01.ASN.0000050222.86847.EA
M3 - Article
C2 - 12595517
AN - SCOPUS:0037369893
SN - 1046-6673
VL - 14
SP - 786
EP - 791
JO - Journal of the American Society of Nephrology
JF - Journal of the American Society of Nephrology
IS - 3
ER -